Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.56 USD 6.63% Market Closed
Market Cap: 554.4m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mind Medicine (MindMed) Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Total Current Assets
$299.4m
CAGR 3-Years
27%
CAGR 5-Years
153%
CAGR 10-Years
99%
Bausch Health Companies Inc
TSX:BHC
Total Current Assets
$5.4B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
2%
Sundial Growers Inc
NASDAQ:SNDL
Total Current Assets
CA$406.9m
CAGR 3-Years
51%
CAGR 5-Years
80%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Total Current Assets
$935.3m
CAGR 3-Years
-7%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Total Current Assets
CA$397.6m
CAGR 3-Years
5%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Total Current Assets
$483.8m
CAGR 3-Years
9%
CAGR 5-Years
446%
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
554.4m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
3.7 USD
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Total Current Assets?
Total Current Assets
299.4m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Total Current Assets amounts to 299.4m USD.

What is Mind Medicine (MindMed) Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
99%

Over the last year, the Total Current Assets growth was 149%. The average annual Total Current Assets growth rates for Mind Medicine (MindMed) Inc have been 27% over the past three years , 153% over the past five years , and 99% over the past ten years .

Back to Top